Back to list
Successful regulatory inspections and GMP renewal
January 16, 2024

Recent regulatory inspections by European Authorities culminated in the successful acquisition of two GMP certificates:

· Part I underscores our commitment to sterile peptides and contract laboratory excellence, aligning with Annex 1 standards.
· Part II extends this commitment across our entire peptide portfolio.

These achievements amplify our dedication to producing high-quality peptide Active Pharmaceutical Ingredients (APIs) and our continuous efforts to meet and exceed industry standards. Grateful for our team’s hard work and dedication!